(Total Views: 838)
Posted On: 06/05/2022 5:57:53 PM
Post# of 145
$NWBO's spun clinical trial data has many flaws that FDA is not likely to buy. A recent post on Seeking Alpha provides a good description of the deficiencies in their "new" trial design:
https://seekingalpha.com/news/3836107-nwbo-st...0a%20panel.
https://seekingalpha.com/news/3836107-nwbo-st...0a%20panel.
(0)
(0)
Scroll down for more posts ▼